Zobrazeno 41 - 50
of 337
pro vyhledávání: '"Jan Cerny"'
Publikováno v:
Leukemia & Lymphoma. 62:2022-2025
Diffuse large B-cell lymphoma (DLBCL) accounts for approximately 25% of non-Hodgkin lymphoma cases [1]. Although often treatment-responsive, 30–40% of DLBCL patients develop refractory or relapsed ...
Autor:
Shyam A Patel, William K Gerber, Lloyd Hutchinson, Jan Cerny, Muthalagu Ramanathan, Andrew Gillis-Smith, Sakiko Suzuki, Salwa Khedr, Bruce Woda, William Selove, Jonathan M Gerber
Publikováno v:
Blood. 140:9150-9151
Autor:
Guru Subramanian Guru Murthy, Soyoung Kim, Zhen-Huan Hu, Noel Estrada-Merly, Muhammad Bilal Abid, Mahmoud Aljurf, Ulrike Bacher, Sherif M. Badawy, Amer Beitinjaneh, Chris Bredeson, Jean-Yves Cahn, Jan Cerny, Miguel Angel Diaz Perez, Nosha Farhadfar, Robert Peter Gale, Siddhartha Ganguly, Usama Gergis, Gerhard C. Hildebrandt, Michael R. Grunwald, Shahrukh Hashmi, Nasheed M. Hossain, Matt Kalaycio, Rammurti T. Kamble, Mohamed A. Kharfan-Dabaja, Betty Ky Hamilton, Hillard M. Lazarus, Jane Liesveld, Mark Litzow, David I. Marks, Hemant S. Murthy, Sunita Nathan, Aziz Nazha, Taiga Nishihori, Sagar S. Patel, Attaphol Pawarode, David Rizzieri, Bipin Savani, Sachiko Seo, Melhem Solh, Celalettin Ustun, Marjolein van der Poel, Leo F. Verdonck, Ravi Vij, Baldeep Wirk, Betul Oran, Ryotaro Nakamura, Bart Scott, Wael Saber
Publikováno v:
JAMA Oncology, 8(3), 404-411. American Medical Association
JAMA Oncol
JAMA Oncol
Importance Matched sibling donors (MSDs) are preferred for allogeneic hematopoietic cell transplantation (allo-HCT) in myelodysplastic syndrome even if they are older. However, whether older MSDs or younger human leukocyte antigen-matched unrelated d
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::639bda17f43fbaee45fe98e0c1f19058
https://cris.maastrichtuniversity.nl/en/publications/7f0ea0f4-e0d2-4f89-b272-9faba5655f2c
https://cris.maastrichtuniversity.nl/en/publications/7f0ea0f4-e0d2-4f89-b272-9faba5655f2c
Publikováno v:
International Medical Case Reports Journal
Bacillus Calmette–Guérin (BCG) has been studied in various cancers for its immune modulation. Although the mechanism is yet to be completely understood, we do have positive experiences in many oncological cases. Hereby, we present a case of an 82-
Autor:
María Teresa Ramírez-Herrera, Néstor Corona, Jan Černý, Krzysztof Gaidzik, Daisuke Sugawara, Steven L. Forman, María Luisa Machain-Castillo, Avto Gogichaishvili
Publikováno v:
Communications Earth & Environment, Vol 5, Iss 1, Pp 1-9 (2024)
Abstract Globally, the largest tsunamigenic earthquakes have occurred along subduction zones. Devastating events exceeding magnitude 9, such as those in Chile, Sumatra, and Japan, struck in regions lacking instrumental records of similar events. Desp
Externí odkaz:
https://doaj.org/article/1cf64d41fd1e4978bdaf110c4d4deed0
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Neel S. Bhatt, Amer Beitinjaneh, J Kwok, S Ganguly, S Gerull, Ibrahim Ahmed, R T Kamble, Ruta Brazauskas, Anita J. Kumar, Christopher Bredeson, Nosha Farhadfar, S Hong, Theresa Hahn, Sachiko Seo, Richard F. Olsson, Matthew L. Ulrickson, Leo F. Verdonck, Yoshiko Atsuta, Anna Barata, Usama Gergis, David A. Rizzieri, Baldeep Wirk, Jennifer M. Knight, H. Schouten, Y. Inamoto, Jan Cerny, Wael Saber, Tamila L. Kindwall-Keller, Hemant S. Murthy, David Buchbinder, Keith M. Sullivan, David Szwajcer, Naya He, J Tay, M Aljurf, Stefan O. Ciurea, Saurabh Chhabra, Jignesh Dalal, Hillard M. Lazarus, Anita D'Souza, Amir Steinberg, Sara Beattie, Nandita Khera, Cesar O. Freytes, Medhat Askar, M Angel Diaz-Perez, Sherif M. Badawy, Y N Koleva, Jeff Szer, Hélène Schoemans, William A. Wood, Jean A. Yared
Publikováno v:
Current Oncology; Volume 27; Issue 6; Pages: 596-606
Curr Oncol
Current Oncology, 27(6), E596-E606. Multimed Inc.
Curr Oncol
Current Oncology, 27(6), E596-E606. Multimed Inc.
BACKGROUND: Evidence about the impact of marital status before hematopoietic cell transplantation (hct) on outcomes after hct is conflicting. METHODS: We identified patients 40 years of age and older within the Center for International Blood and Marr
Autor:
Alois Gratwohl, Jason Law, David Szwajcer, Jean A. Yared, Bronwen E. Shaw, Ruta Brazauskas, Amer Beitinjaneh, Matthew L. Ulrickson, Hisham Abdel-Azim, Sara Beattie, Navneet S. Majhail, Shahrukh K. Hashmi, J. Douglas Rizzo, Wael Saber, Neel S. Bhatt, William A. Wood, Charles F. LeMaistre, Stephanie J. Lee, Bipin N. Savani, Sherif M. Badawy, Stefan O. Ciurea, Richard F. Olsson, David A. Rizzieri, Hasan Hashem, Sachiko Seo, Sanghee Hong, Jan Cerny, Akshay Sharma, Kyle Hebert, Hélène Schoemans, Hillard M. Lazarus, Ayami Yoshimi, Rammurti T. Kamble, Siddhartha Ganguly, Nosha Farhadfar, Theresa Hahn, Miguel Angel Diaz, Nandita Khera, Mahmoud Aljurf, Usama Gergis
Publikováno v:
Cancer
Cancer, vol 127, iss 4
Cancer, vol 127, iss 4
Background The association of community factors and outcomes after hematopoietic cell transplantation (HCT) has not been comprehensively described. Using the County Health Rankings and Roadmaps (CHRR) and the Center for International Blood and Marrow
Autor:
Wael Saber, Ann E. Woolfrey, Tamila L. Kindwall-Keller, Uday R. Popat, Melhem Solh, Mahmoud Aljurf, Robert Peter Gale, Ryotaro Nakamura, Taiga Nishihori, Bipin N. Savani, Mark R. Litzow, Amer Beitinjaneh, Rammurti T. Kamble, Richard F. Olsson, Sachiko Seo, Jean A. Yared, Jeff Szer, Jane L. Liesveld, Usama Gergis, Betty K. Hamilton, Zhen-Huan Hu, Siddhartha Ganguly, Jan Cerny, Soyoung Kim, Jean-Yves Cahn, Edward A. Copelan, Edwin P. Alyea, Leo F. Verdonck, Biju George, Shahrukh K. Hashmi, Shahinaz M. Gadalla, Aaron T. Gerds, Ying Liu, Bart L. Scott, Gerhard C. Hildebrandt, Baldeep Wirk, Vikas Gupta, Ronald Sobecks, Richard T. Maziarz, Hillard M. Lazarus, David A. Rizzieri, Ulrike Bacher
Publikováno v:
Blood Advances. 4:4748-4757
Comparative outcomes of allogeneic hematopoietic cell transplantation (HCT) for BCR-ABL1− myeloproliferative neoplasms (MPNs) in blast phase (MPN-BP) vs de novo acute myeloid leukemia (AML), and AML with prior myelodysplastic syndromes (MDSs; post-
Publikováno v:
Acta Haematologica. 144:297-301
Acute myeloid leukemia (AML) is a stem cell malignancy that originates in the bone marrow and involves the peripheral blood. Extramedullary AML is rarer, but it is most commonly associated with the former French-American-British (FAB) subtypes M4 or